Quadrant Capital Group LLC Cure Vac N.V. Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 30,918 shares of CVAC stock, worth $117,179. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,918
Previous 34,078
9.27%
Holding current value
$117,179
Previous $115,000
21.74%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding CVAC
# of Institutions
87Shares Held
12.2MCall Options Held
164KPut Options Held
117K-
Israel Englander Millennium Management LLC | New York, Ny2.42MShares$9.16 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$8.54 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$5.95 Million10.6% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.01MShares$3.83 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct780KShares$2.96 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $710M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...